MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
Recruiting · NCT05710380 · Registry updated 2026-09-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate adenocarcinoma, prostate cancer, prostate disorder | Recruiting | Not applicable | 2026-09-01 | NCT05710380 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
| University of Chicago | 326 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Oregon Health & Science University | Portland | United States | 261 |
| University of Chicago Medicine Comprehensive Cancer Center | Chicago | United States | 26 |